Neumora Therapeutics
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | -5,000 | ||
EBITDA | -57,405 | -55,985 | -54,021 |
EBIT | -57,414 | -56,008 | -54,040 |
Net Income | -59,450 | -56,755 | -52,731 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -47,939 | -46,649 | -52,404 |
Cash | 182,530 | 129,071 | 124,523 |
Basic Shares | 163,391 | 161,838 | 161,691 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -5,000 | -668 | -2,697 | |
EBITDA | -233,371 | -262,833 | -187,526 | -135,276 |
EBIT | -233,579 | -263,464 | -188,194 | -135,870 |
Net Income | -236,928 | -243,787 | -235,925 | -130,904 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -206,440 | -182,936 | -163,395 | -115,407 |
Cash | 182,530 | 142,148 | 374,038 | 240,943 |
Basic Shares | 163,391 | 159,377 | 158,832 | 151,949 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.30 |
2025-12-31 | -$0.35 |
2025-09-30 | -$0.35 |
2025-06-30 | -$0.33 |